Shares of Acelyrin climbed after the company said it has received an unsolicited indication of interest from Concentra Biosciences for an acquisition at $3 a share. The stock was up 14% at $2.48 in ...

Explore China's economic growth prospects and ETF opportunities like FLCH. See here for performance insights, competitive P/E ...

Aptose Biosciences advances its Phase 1/2 TUSCANY trial, escalating tuspetinib dosing after a favorable safety review. Enrollment continues across U.S. sites.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

NEW YORK, Feb. 3, 2025 /PRNewswire/ -- As the healthcare sector embarks on a transformative year ahead, AlphaSense, the leading market intelligence and search platform, continues to solidify its ...

Strength in the Electronic Instruments Group segment on the back of benefits from Virtek Vision International, Navitar, Alphasense ... expert as the #1 favorite stock to gain +100% or more ...

CPKC President and CEO Keith Creel and CPKC EVP and COO Mark Redd will now address the 2024 UBS Global Industrials and Transportation Conference on Dec. 4 ...

For more information, see our expert panel. Stock trading apps empower investors to buy and sell securities directly from the convenience of their mobile devices. The best stock trading apps ...

The shares closed the day at $367.74, down 8.3% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the ...